Search Results - "Philippens, I."

Refine Results
  1. 1

    Citrullinated human and murine MOG35–55 display distinct biophysical and biochemical behavior by Doelman, W., Reijnen, R.C., Dijksman, N., Janssen, A.P.A., van Driel, N., ’t Hart, B.A., Philippens, I., Araman, C., Baron, W., van Kasteren, S.I.

    Published in The Journal of biological chemistry (01-04-2023)
    “…The peptide spanning residues 35 to 55 of the protein myelin oligodendrocyte glycoprotein (MOG) has been studied extensively in its role as a key autoantigen…”
    Get full text
    Journal Article
  2. 2

    Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage by Franke, S.K, van Kesteren, R.E, Wubben, J.A.M, Hofman, S, Paliukhovich, I, van der Schors, R.C, van Nierop, P, Smit, A.B, Philippens, I.H.C.H.M

    Published in Neuroscience (15-01-2016)
    “…Highlights • A chronic slow progressive marmoset MPTP model for early PD progression and recovery is presented. • Parkinsonian symptoms can occur without…”
    Get full text
    Journal Article
  3. 3

    Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy by van Vlieta, S.A.M, Blezer, E.L.A, Jongsma, M.J, Vanwersch, R.A.P, Olivier, B, Philippens, I.H.C.H.M

    Published in Brain research (16-01-2008)
    “…Abstract Neuroprotective therapeutics stop or slow down the degeneration process in animal models of Parkinson's disease (PD). Neuronal survival in PD animal…”
    Get full text
    Journal Article
  4. 4

    Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour by de Groot, D. M. G., Bierman, E. P. B., Bruijnzeel, P. L. B., Carpentier, P., Kulig, B. M., Lallement, G., Melchers, B. P. C., Philippens, I. H. C. H. M., van Huygevoort, A. H. B. M.

    Published in Journal of applied toxicology (01-12-2001)
    “…Poisoning with the potent nerve agent soman produces a cascade of central nervous system (CNS) effects characterized by severe convulsions and eventually…”
    Get full text
    Journal Article
  5. 5

    Subchronic Physostigmine Pretreatment in Marmosets: Absence of Side Effects and Effectiveness against Soman Poisoning with Negligible Postintoxication Incapacitation by Philippens, I. H. C. H. M., Vanwersch, R. A. P., Groen, B., Olivier, B., Bruijnzeel, P. L. B., Melchers, B. P. C.

    Published in Toxicological sciences (01-01-2000)
    “…Subchronic pretreatment with physostigmine (PHY) (0.0125 mg/kg/h) leading to a blood acetylcholinesterase inhibition of about 30% caused no side effects when…”
    Get full text
    Journal Article
  6. 6

    Scopolamine Augments the Efficacy of Physostigmine Against Soman Poisoning in Guinea Pigs by Philippens, Ingrid H.C.H.M, Melchers, Bert P.C, Olivier, Berend, Bruijnzeel, Piet L.B

    “…The efficacy of the subchronically administered cholinesterase-inhibitor physostigmine (PHY) (0.025 mg/kg/h) either with or without the muscarinergic receptor…”
    Get full text
    Journal Article
  7. 7

    Effects of Physostigmine on the Startle in Guinea Pigs: Two Mechanisms Involved by Philippens, I.H.C.H.M, Olivier, B, Melchers, B.P.C

    Published in Pharmacology, biochemistry and behavior (01-12-1997)
    “…The effects of the acetylcholinesterase inhibitor physostigmine (PHY) on the auditory startle reflex in guinea pigs were studied. The dose–response curve of…”
    Get full text
    Journal Article
  8. 8

    Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys by BUSKER, R. W, ZIJLSTRA, J. J, PHILIPPENS, I. H. C. H. M, GROEN, B, MELCHERS, B. P. C

    Published in Toxicology (Amsterdam) (02-09-1996)
    “…The therapeutic efficacy of single or repeated doses of HI-6, together with atropine, against soman poisoning were compared both in guinea pigs and in marmoset…”
    Get full text
    Journal Article
  9. 9

    Citrullinated human and murine MOG 35-55 display distinct biophysical and biochemical behavior by Doelman, W, Reijnen, R C, Dijksman, N, Janssen, A P A, van Driel, N, 't Hart, B A, Philippens, I, Araman, C, Baron, W, van Kasteren, S I

    Published in The Journal of biological chemistry (01-04-2023)
    “…The peptide spanning residues 35 to 55 of the protein myelin oligodendrocyte glycoprotein (MOG) has been studied extensively in its role as a key autoantigen…”
    Get full text
    Journal Article
  10. 10

    Side effects of physostigmine as a pretreatment in guinea pigs by Philippens, Ingrid H.C.H.M., Wolthuis, Otto L., Busker, Ruud W., Langenberg, Jan P., Melchers, Bert P.C.

    Published in Pharmacology, biochemistry and behavior (01-09-1996)
    “…To prevent incapacitation following nerve agent intoxications, it is proposed to replace pyridostigmine by the centrally active carbamate physostigmine (PHY)…”
    Get full text
    Journal Article
  11. 11

    Efficacy of HI-6 and HLö-7 in preventing incapacitation following nerve agent poisoning by Melchers, B P, Philippens, I H, Wolthuis, O L

    Published in Pharmacology, biochemistry and behavior (01-12-1994)
    “…The therapeutic efficacy of the oximes HI-6 and HLö-7 (132.5 mumol/kg), in combination with atropine, in soman- or tabun-intoxicated guinea pigs was compared,…”
    Get more information
    Journal Article
  12. 12

    Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats by Philippens, I H, Melchers, B P, de Groot, D M, Wolthuis, O L

    Published in Pharmacology, biochemistry and behavior (01-08-1992)
    “…It is known that rats poisoned with near-lethal doses of pinacolyl methylphosphonofluoridate (soman) develop brain lesions, particularly when convulsions are…”
    Get more information
    Journal Article
  13. 13

    A simple automated test to measure exploratory and motor activity of marmosets by Wolthuis, O L, Groen, B, Philippens, I H

    Published in Pharmacology, biochemistry and behavior (01-04-1994)
    “…An automated device is described to test the exploratory and motor activity of common marmosets (Callithrix jacchus). The device consists of four boxes…”
    Get more information
    Journal Article
  14. 14

    On the development of behavioral tolerance to organophosphates. III: Behavioral aspects by Wolthuis, O L, Philippens, I H, Vanwersch, R

    Published in Pharmacology, biochemistry and behavior (01-03-1990)
    “…As part of a study on the mechanisms underlying behavioral tolerance to cholinesterase-inhibiting organophosphates (OP's) the present investigation was…”
    Get more information
    Journal Article
  15. 15

    Side effects of therapeutic drugs against organophosphate poisoning by Wolthuis, O L, Philippens, I H, Vanwersch, R A

    Published in Neurotoxicology and teratology (01-05-1989)
    “…The possible side effects of therapeutic drugs against organophosphate poisoning were investigated. First, dose-effect curves were obtained with atropine…”
    Get more information
    Journal Article
  16. 16

    Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease by Philippens, Ingrid H, Ormel, Paul R, Baarends, Guus, Johansson, Maja, Remarque, Ed J, Doverskog, Magnus

    Published in Journal of Alzheimer's disease (01-01-2017)
    “…The immune system is increasingly mentioned as a potential target for Alzheimer's disease (AD) treatment. In the present pilot study, the effect of…”
    Get more information
    Journal Article
  17. 17

    Behavioral test systems in marmoset monkeys by Philippens, I H, Melchers, B P, Roeling, T A, Bruijnzeel, P L

    “…A number of neurobehavioral methods have been developed to test behavior in marmoset monkeys. These test systems are (1) the bungalow test, which quantifies…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Subchronic Physostigmine Pretreatment in Guinea Pigs: Effective Against Soman and Without Side Effects by Philippens, Ingrid H.C.H.M, Busker, Ruud W, Wolthuis, Otto L, Olivier, Berend, Bruijnzeel, Piet L.B, Melchers, Bert P.C

    Published in Pharmacology, biochemistry and behavior (01-04-1998)
    “…The behavioral and neurophysiological effects of the subchronically administered cholinesterase-inhibitor physostigmine (PHY) (0.025 mg/kg/h) either with or…”
    Get full text
    Journal Article
  20. 20